Scott Wheelwright
Direttore operativo presso Beijing Bioinno Bioscience Co., Ltd.
Profilo
Scott M.
Wheelwright was the founder of Innovent Biologics, Inc. founded in 2011 where he held the title of Vice President from 2011 to 2015.
He is currently the Chief Operating Officer at Beijing BioInno Bioscience Co., Ltd.
Dr. Wheelwright's former jobs include Senior Director-Process Development at Scios, Inc., Biochemical Engineer at Abbott Laboratories, Vice President-Manufacturing & Operations at DURECT Corp., Vice President-Bioprocessing at Genitope Corp., Vice President-Operations at Iris BioTechnologies, Inc. from 2004 to 2009, and Vice President-Development & Manufacturing at Calydon, Inc. Dr. Wheelwright's education history includes an undergraduate degree from the University of Utah and a doctorate degree from the University of California, Berkeley.
Posizioni attive di Scott Wheelwright
| Società | Posizione | Inizio |
|---|---|---|
Beijing Bioinno Bioscience Co., Ltd.
 Beijing Bioinno Bioscience Co., Ltd. BiotechnologyHealth Technology Beijing Bioinno Bioscience Co. Ltd. is a clinical-stage biopharmaceutical company located in China. | Direttore operativo | - |
Precedenti posizioni note di Scott Wheelwright
| Società | Posizione | Fine |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | - |
| INNOVENT BIOLOGICS, INC. | Fondatore | - |
Calydon, Inc.
 Calydon, Inc. Medical SpecialtiesHealth Technology Part of ANI Pharmaceuticals, Inc., Calydon, Inc. develops therapeutic products for cancer. The company is based in Sunnyvale, CA. Calydon was acquired by Cell Genesys, Inc. on September 05, 2001 for $17.68 million. | Corporate Officer/Principal | - |
| DURECT CORPORATION | Direttore operativo | - |
Formazione di Scott Wheelwright
| University of Utah | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| DURECT CORPORATION | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Iris BioTechnologies, Inc.
 Iris BioTechnologies, Inc. Medical SpecialtiesHealth Technology Iris Biotechnologies, Inc. is life sciences company focused on health care. It offers the best approach to the treatment of cancer and other diseases through actionable integration of molecular profiling in the clinical decision-making process. The Iris Nano-Biochip product pipeline include CancerChip, PrenatalChip, Integrated Blood Test, IVF applications, NeuroChip, MetabolicChip, CardioChip, and Chips for veterinary, agricultural, environmental, and other applications. The company was founded by Simon Chin on February 16, 1999 and is headquartered in Santa Clara, CA. | Health Technology |
Calydon, Inc.
Calydon, Inc. Medical SpecialtiesHealth Technology Part of ANI Pharmaceuticals, Inc., Calydon, Inc. develops therapeutic products for cancer. The company is based in Sunnyvale, CA. Calydon was acquired by Cell Genesys, Inc. on September 05, 2001 for $17.68 million. | Health Technology |
Beijing Bioinno Bioscience Co., Ltd.
Beijing Bioinno Bioscience Co., Ltd. BiotechnologyHealth Technology Beijing Bioinno Bioscience Co. Ltd. is a clinical-stage biopharmaceutical company located in China. | Health Technology |
- Borsa valori
- Insiders
- Scott Wheelwright
